Avaí Bio, Inc. (AVAI)

Avaí Bio Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	-	-	-	0.28	0.92	1.21
Revenue Growth (YoY)	-	-	-	-70.01%	-24.12%	69.23%
Cost of Revenue	-	-	-	0.32	0.71	1.23
Gross Profit	-	-	-	-0.04	0.21	-0.02
Selling, General & Admin	1.29	1.46	2.04	0.3	0.51	0.23
Research & Development	0.02	-	-	-	-	-
Other Operating Expenses	-0.32	-0.39	0.01	-0.01	-0.22	-0
Operating Expenses	1.03	1.14	2.13	0.31	0.34	0.29
Operating Income	-1.03	-1.14	-2.13	-0.35	-0.13	-0.3
Other Non Operating Income (Expenses)	-	-	-	0	-	-
Pretax Income	-1.03	-1.14	-2.13	-0.35	-0.13	-0.3
Net Income	-1.03	-1.14	-2.13	-0.35	-0.13	-0.3
Net Income to Common	-1.03	-1.14	-2.13	-0.35	-0.13	-0.3
Shares Outstanding (Basic)	138	128	87	39	26	26
Shares Outstanding (Diluted)	138	128	87	39	26	26
Shares Change (YoY)	5.72%	48.09%	124.74%	46.31%	0.13%	29.15%
EPS (Basic)	-0.01	-0.01	-0.02	-0.01	-0.00	-0.01
EPS (Diluted)	-0.01	-0.01	-0.02	-0.01	-0.00	-0.01
Free Cash Flow	-1.15	-1.16	-1.32	-0.05	-0.54	-0.02
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.00	-0.02	-0.00
Gross Margin	-	-	-	-14.64%	22.88%	-1.36%
Operating Margin	-	-	-	-126.28%	-13.73%	-24.90%
Profit Margin	-	-	-	-126.28%	-13.73%	-24.90%
Free Cash Flow Margin	-	-	-	-19.71%	-58.07%	-1.90%
EBITDA	-0.99	-1.07	-2.05	-0.33	-0.09	-0.25
EBITDA Margin	-	-	-	-117.80%	-9.77%	-20.46%
D&A For EBITDA	0.04	0.07	0.08	0.02	0.04	0.05
EBIT	-1.03	-1.14	-2.13	-0.35	-0.13	-0.3
EBIT Margin	-	-	-	-126.28%	-13.73%	-24.90%
Revenue as Reported	-	-	-	0.28	0.92	1.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.